This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aarnoutse, R. E.
Right arrow Articles by Burger, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aarnoutse, R. E.
Right arrow Articles by Burger, D. M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2002, p. 884-886, Vol. 46, No. 3
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.3.884-886.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma

Rob E. Aarnoutse,1* Corrien P. W. G. M. Verweij-van Wissen,1 Eleonora W. J. van Ewijk-Beneken Kolmer,1 Eveline W. Wuis,1 Peter P. Koopmans,2 Yechiel A. Hekster,1 and David M. Burger1

Department of Clinical Pharmacy,1 Department of General Internal Medicine, University Medical Centre Nijmegen, Nijmegen, The Netherlands2

Received 7 June 2001/ Returned for modification 3 October 2001/ Accepted 3 December 2001

An international interlaboratory quality control program for measurement of antiretroviral drugs was initiated. The first round was confined to protease inhibitors and showed large variability in the performance of participating laboratories. The results demonstrate the need for and utility of an ongoing quality control program in this area of bioanalysis.

* Corresponding author. Mailing address: Department of Clinical Pharmacy, University Medical Centre Nijmegen, P. O. Box 9101, 533 KF, 6500 HB, Nijmegen, The Netherlands. Phone: 31-24-3616405. Fax: 31-24-3540331. E-mail: R.Aarnoutse{at}klinfarm.azn.nl.

Antimicrobial Agents and Chemotherapy, March 2002, p. 884-886, Vol. 46, No. 3
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.3.884-886.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Rakhmanina, N., van den Anker, J., Baghdassarian, A., Soldin, S., Williams, K., Neely, M. N. (2009). Population Pharmacokinetics of Lopinavir Predict Suboptimal Therapeutic Concentrations in Treatment-Experienced Human Immunodeficiency Virus-Infected Children. Antimicrob. Agents Chemother. 53: 2532-2538 [Abstract] [Full Text]  
  • Bruggemann, R. J. M., Touw, D. J., Aarnoutse, R. E., Verweij, P. E., Burger, D. M. (2009). International Interlaboratory Proficiency Testing Program for Measurement of Azole Antifungal Plasma Concentrations. Antimicrob. Agents Chemother. 53: 303-305 [Abstract] [Full Text]  
  • Holland, D. T., DiFrancesco, R., Stone, J., Hamzeh, F., Connor, J. D., Morse, G. D. (2004). Quality Assurance Program for Clinical Measurement of Antiretrovirals: AIDS Clinical Trials Group Proficiency Testing Program for Pediatric and Adult Pharmacology Laboratories. Antimicrob. Agents Chemother. 48: 824-831 [Abstract] [Full Text]  
  • Liedtke, M. D, Lockhart, S. M, Rathbun, R C. (2004). Anticonvulsant and Antiretroviral Interactions. The Annals of Pharmacotherapy 38: 482-489 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»